Provided by Tiger Fintech (Singapore) Pte. Ltd.

Valneva SE

6.28
+0.03080.49%
Volume:4.73K
Turnover:29.81K
Market Cap:534.00M
PE:-5.39
High:6.45
Open:6.28
Low:6.19
Close:6.25
Loading ...

Valneva Renews ATM Stock Offering Agreement

MT Newswires Live
·
27 Mar

Valneva Renews its Sales Agreement in connection with its Existing At-the-Market (ATM) Program

GlobeNewswire
·
27 Mar

Valneva to provide 40,000 IXCHIQ doses in France starting early April

TIPRANKS
·
26 Mar

Stock Track | Valneva SE Plummets 5.25% Following $350 Million Shelf Registration Filing

Stock Track
·
25 Mar

Stock Track | Valneva Plummets 5.25% Following $350 Million Shelf Registration Filing

Stock Track
·
25 Mar

Valneva Files $350 Million Shelf

MT Newswires Live
·
25 Mar

Valneva (VALN) Receives a Buy from H.C. Wainwright

TIPRANKS
·
25 Mar

Valneva Price Target Maintained With a $17.00/Share by HC Wainwright & Co.

Dow Jones
·
25 Mar

Stock Track | Valneva Soars 7.81% Pre-market on Chikungunya Vaccine Supply Deal for La Réunion Outbreak

Stock Track
·
24 Mar

Valneva Is Maintained at Buy by Guggenheim

Dow Jones
·
24 Mar

Stock Track | Valneva Soars 7.25% Pre-market on Chikungunya Vaccine Supply for La Réunion Outbreak

Stock Track
·
24 Mar

Stock Track | Valneva SE Surges 7.25% Pre-market on Chikungunya Vaccine Supply for La Réunion Outbreak

Stock Track
·
24 Mar

Valneva Se : Guggenheim Cuts Target Price to $15 From $17

THOMSON REUTERS
·
24 Mar

Valneva Responds to French Government’s Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion

GlobeNewswire
·
24 Mar

Valneva Price Target Maintained With a $17.00/Share by HC Wainwright & Co.

Dow Jones
·
21 Mar

Valneva SE (INRLF) (FY 2024) Earnings Call Highlights: Strong Sales Growth and Strategic ...

GuruFocus.com
·
21 Mar

Valneva SE reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
20 Mar

Stock Track | Valneva Soars 11.29% Pre-Market on Strong 2024 Results and Positive 2025 Outlook

Stock Track
·
20 Mar

Pharming For 2025 Expects Product Sales Of €170M–180M And Total Revenues Of €180M–190M; Sees R&D Investments Of €90M–100M

Benzinga
·
20 Mar

Valneva FY Sales €169.60M Up From €153.7M YoY, Net Loss €12.2M Compared To Net Loss €101.4M YoY

Benzinga
·
20 Mar